Amicus Therapeutics
FOLD
#3208
Rank
A$6.87 B
Marketcap
A$21.89
Share price
0.00%
Change (1 day)
89.01%
Change (1 year)

Market capitalization of Amicus Therapeutics (FOLD)

Last known market cap: A$6.87 Billion

As of November 2026 Amicus Therapeutics has a market cap of A$6.87 Billion. This makes Amicus Therapeutics the world's 3208th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Amicus Therapeutics from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026A$6.87 B4.46%
2025A$6.58 B42.24%
2024A$4.62 B-24.26%
2023A$6.10 B21.16%
2022A$5.04 B13.56%
2021A$4.43 B-43.27%
2020A$7.82 B120.22%
2019A$3.55 B37.97%
2018A$2.57 B-15.97%
2017A$3.06 B212.3%
2016A$0.98 B-41.05%
2015A$1.66 B71.37%
2014A$0.97 B494.96%
2013A$0.16 B27.57%
2012A$0.12 B10.09%
2011A$0.11 B-27.19%
2010A$0.15 B59.36%
2009A$0.10 B-60.16%
2008A$0.25 B-8.01%
2007A$0.27 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novo Nordisk
NVO
A$251.82 B 3,563.54%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Biogen
BIIB
A$55.74 B 710.89%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$144.63 B 2,004.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
A$1.02 B-85.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$1.23 B-81.99%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$17.67 B 157.17%๐Ÿ‡บ๐Ÿ‡ธ USA